Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.44M Sell
24,000
-261,000
-92% -$93M ﹤0.01% 1582
2025
Q4
$93.3M Buy
285,000
+127,200
+81% +$40.3M 0.04% 397
2025
Q3
$44.5M Buy
157,800
+121,600
+336% +$35.3M 0.02% 674
2025
Q2
$10.1M Sell
36,200
-27,600
-43% -$7.82M 0.01% 1364
2025
Q1
$19.9M Buy
63,800
+18,800
+42% +$5.55M 0.01% 976
2024
Q4
$11.7M Sell
45,000
-24,500
-35% -$7.27M 0.01% 1275
2024
Q3
$22.4M Buy
69,500
+24,500
+54% +$8.01M 0.01% 884
2024
Q2
$14.1M Buy
+45,000
New +$13.2M 0.01% 1072
2023
Q3
Sell
-12,000
Closed -$2.66M 5661
2023
Q2
$2.66M Sell
12,000
-25,100
-68% -$5.82M ﹤0.01% 1956
2023
Q1
$8.97M Sell
37,100
-132,500
-78% -$32.5M 0.01% 1212
2022
Q4
$44.5M Buy
169,600
+12,100
+8% +$3.24M 0.04% 443
2022
Q3
$35.5M Sell
157,500
-78,000
-33% -$18.9M 0.03% 512
2022
Q2
$57.3M Sell
235,500
-307,000
-57% -$75.2M 0.04% 351
2022
Q1
$131M Buy
542,500
+128,300
+31% +$29.5M 0.08% 224
2021
Q4
$93.2M Buy
414,200
+138,800
+50% +$29.3M 0.05% 340
2021
Q3
$58.6M Buy
275,400
+126,100
+84% +$29M 0.03% 471
2021
Q2
$36.4M Buy
149,300
+50,000
+50% +$12.3M 0.02% 672
2021
Q1
$24.7M Sell
99,300
-104,800
-51% -$25M 0.02% 838
2020
Q4
$46.9M Sell
204,100
-1,100
-0.5% -$254K 0.03% 571
2020
Q3
$52.2M Buy
205,200
+77,700
+61% +$19.2M 0.03% 436
2020
Q2
$30.1M Sell
127,500
-69,100
-35% -$15.8M 0.02% 607
2020
Q1
$39.9M Sell
196,600
-70,600
-26% -$15.4M 0.04% 449
2019
Q4
$64.4M Buy
267,200
+84,400
+46% +$18.6M 0.05% 400
2019
Q3
$35.4M Sell
182,800
-37,700
-17% -$7.24M 0.03% 608
2019
Q2
$40.6M Sell
220,500
-174,300
-44% -$31.2M 0.03% 538
2019
Q1
$75M Buy
394,800
+80,500
+26% +$15.4M 0.07% 255
2018
Q4
$61.2M Buy
314,300
+33,000
+12% +$6.44M 0.06% 321
2018
Q3
$58.3M Buy
281,300
+134,500
+92% +$26.5M 0.05% 331
2018
Q2
$27.1M Sell
146,800
-71,800
-33% -$12.7M 0.02% 622
2018
Q1
$37.3M Sell
218,600
-38,100
-15% -$6.99M 0.03% 498
2017
Q4
$44.6M Buy
256,700
+1,300
+0.5% +$230K 0.04% 473
2017
Q3
$47.6M Sell
255,400
-26,400
-9% -$4.68M 0.04% 422
2017
Q2
$48.5M Sell
281,800
-23,400
-8% -$3.81M 0.04% 363
2017
Q1
$50.1M Buy
305,200
+120,400
+65% +$20M 0.04% 361
2016
Q4
$27M Sell
184,800
-89,300
-33% -$13.4M 0.02% 613
2016
Q3
$45.7M Buy
274,100
+26,600
+11% +$4.5M 0.04% 365
2016
Q2
$37.7M Sell
247,500
-15,200
-6% -$2.36M 0.04% 402
2016
Q1
$39.4M Buy
262,700
+74,200
+39% +$11M 0.04% 361
2015
Q4
$30.6M Sell
188,500
-71,500
-28% -$11.2M 0.03% 544
2015
Q3
$36M Buy
260,000
+33,300
+15% +$5.25M 0.03% 448
2015
Q2
$34.8M Buy
226,700
+34,500
+18% +$5.53M 0.03% 514
2015
Q1
$30.7M Sell
192,200
-104,300
-35% -$16.4M 0.03% 558
2014
Q4
$47.2M Buy
296,500
+40,300
+16% +$6.28M 0.04% 426
2014
Q3
$36M Sell
256,200
-6,100
-2% -$796K 0.03% 524
2014
Q2
$31M Buy
262,300
+65,400
+33% +$7.57M 0.03% 542
2014
Q1
$24.3M Sell
196,900
-194,100
-50% -$23.5M 0.02% 606
2013
Q4
$44.6M Sell
391,000
-101,500
-21% -$11.5M 0.04% 410
2013
Q3
$55.1M Buy
492,500
+54,000
+12% +$5.86M 0.05% 328
2013
Q2
$43.3M Buy
+438,500
New +$45.5M 0.04% 368

Other funds holding AMGN

Citigroup's AMGN Position: Q1 2026 in Review

Citigroup increased its Amgen (AMGN) stake by 5.7% in Q1 2026, buying an estimated $15.8M and bringing the position to 828,097 shares worth $291M. The position accounts for 0.12% of the portfolio, ranked #157.

Citigroup first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $320M in Q1 2021. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Citigroup held 828,097 shares of Amgen worth $291M as of Q1 2026.
  • Citigroup bought 44,394 Amgen shares in Q1 2026, an estimated $15.8M.
  • Amgen made up 0.12% of Citigroup's portfolio in Q1 2026, its #157 holding.
  • Citigroup first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Amgen position peaked at $320M in Q1 2021.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.